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1. Introduction 
Abnormal uterine bleeding (AUB) is a common complaint in reproductive age women. The 
World Health Organization reported that in developing countries, 8-27% of women suffered 
heavy menstrual bleeding. (1) Hysterectomy remains the gold-standard treatment, but can 
be associated with significant morbidity. In the past gynecologists will be criticized for 
performing hysterectomies for women with AUB but without any uterine pathology. Over 
the past two decades, several non-invasive or minimally invasive procedures have emerged 
as alternative treatment modalities. But do these new treatments remain effective over time? 
In the present chapter, I discuss first generation hysteroscopic ablation techniques (EA), as 
an alternative to hysterectomy, that have been extensively studied over the last 20 years but 
are actually underused. Because a great number of valuable papers and books have already 
been published on this topic, for the sake of simplicity references have been kept to  
a minimum. Also I will share my personal experiences as a hysteroscopist who has 
performed more than 1000 cases of operative hysteroscopic surgery in Taiwan over the last 
15 years. 
2. Indications for hysterectomy 
A hysterectomy is an operation to remove a woman's uterus. Sometimes, the ovaries and 
fallopian tubes are also removed. Hysterectomies are very common - one in three women in 
the United States has had one by age 60. 
The following benign diseases are the most common reasons for hysterectomy: 
 Abnormal uterine bleeding (AUB) that persists despite treatment  
 Uterine leiomyomata (fibroids) 
 Adenomyosis not cured by medicine or conservative surgery  
 Uterine prolapse - when the uterus drops into the vagina  
 Chronic pelvic pain; intractable to medical treatments 
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Before a patient undergoes a hysterectomy, it is important to discuss alternative treatments 
with the patient. After hysterectomy her periods will stop, and she will no longer be able to get 
pregnant. If both ovaries are removed, a patient will enter menopause. Although hysterectomy 
is one of the most commonly used gynecological procedures, in recent years the number of 
patients undergoing hysterectomy has decreased in some area of the world. (2) 
The possible reasons for this could be the availability of new emerging minimally invasive 
alternative procedures and the adverse effects after hysterectomy. (2,3) Current ‘save the 
uterus ‘ attitude in the world has also become a support to narrow the range of indications 
of hysterectomy. Hysterectomy can alleviate all menstrual-related clinical symptoms, 
including dysmenorrhea and premenstrual symptoms, and the overall patient satisfaction 
rate with this approach is approximately 80%. However, it also has some disadvantages 
such as frequent peri-operative complications, prolonged operating time, delayed recovery, 
and high cost. Recent studies have shown that women below 50 years of age who undergo 
hysterectomy with or without oophorectomy are at a significantly higher risk of all-cause 
mortality and coronary heart diseases. (3, 4) Traditionally, hysterectomy has also been 
known to have a major psychological impact. Over the past 15-20 years, several non-
invasive or minimally invasive procedures have emerged as alternative treatment 
modalities. Currently available alternative treatment modalities include insertion of 
levonorgestrel-intrauterine system (LNG-IUS), myomectomy, myolysis, uterine artery 
embolization, magnetic resonance imaging-focused ultrasonography, hysteroscopic 
endometrial ablation (EA), and second-generation global endometrial ablation. 
3. Alternatives for hysterectomy 
Avoiding unnecessary hysterectomy is a challenge. Abnormal uterine bleeding (AUB), 
defined as excessive or irregular bleeding, occurs in about 10–30% of women of 
reproductive age. Uterine leiomyomata (fibroids) is the most common benign gynecological 
tumor, occurring in about 30% of women. The 2002 report from Organization for Economic 
Co-operation and Development showed that rates ranged from a low of 114 per 100 000 
women in Mexico to a high of 526 in Norway. In Taiwan, the incidence of hysterectomy was 
approximately 268 to 303 per100 000 women from 1996 to 2001. Fibroids are the most 
common indication for hysterectomy in Taiwan; a total of 22,000 hysterectomies are 
performed each year. (5) The overall cost of treating fibroids in US was estimated at $2.1 
billion in 2000. More than 70% of those costs were directly related to hysterectomy. 
Asymptomatic uterine leiomyomata may not require treatment, but in about 20–80% of 
cases, leiomyomata is accompanied by AUB and pelvic symptoms. AUB and leiomyomata 
are the main indications for hysterectomy. If AUB can be successfully treated with 
alternative modalities, then the need for hysterectomy may be reduced. 
Recently, several non-invasive or minimally invasive procedures have emerged as 
alternative treatment modalities include insertion of levonorgestrel-intrauterine system 
(LNG-IUS), myomectomy, myolysis, uterine artery embolization, magnetic resonance 
imaging-focused Ultrasonography. While hysteroscopic endometrial ablation, and second-
generation global endometrial ablation (EA), are to be choiced when menorrhagia is the 
primary indication and endometrial anatomy is appropriate. For patients requiring 
interventional treatment, selection among these procedures depends on the patient’s age, 
symptoms, coexisting conditions, and reproductive plans. 
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EA is a suitable alternative for the treatment of AUB. Resectoscopic techniques are 
performed under hysteroscopic visualization, using resectoscopic instruments to ablate the 
endometrium or remove submucosal leiomyomata. Hysteroscopic EA and myomectomy 
have become increasingly popular treatment modalities for women with AUB. From 2003 to 
2006, in England, EA was performed in 60% of cases of surgically treated AUB. (6)  
The 2009 Cochrane Database meta-analysis of 21 randomized trials regarding resectoscopic 
ablation showed the following results: (a) the amenorrhea rate was 38% at 1 year and 48% at 
2–5 years, (b) the patient satisfaction rate was 88% at 1 year and 87% at 2–5 years, and (c) the 
subsequent surgery rate was 25% for any surgery (including hysterectomy) and 19% for 
hysterectomy alone. (7) Since 1996, I have performed more than 1000 hysteroscopic EAs at 3 
hospitals in Taiwan. The results were comparable to those in other medical literature, but 
had a lower subsequent surgery rate of approximately 5%. (8, 9) In my recent study, I 
followed up 334 women who were eligible for a follow-up after surgery; the follow-up 
duration ranged from 7 months to 109 months (mean, 48.7 months). Of the 334 women, 161 
(48%) had normal flow, 33 (10%) had hypomenorrhea, 31 (9%) had heavy flow, and 82 (25%) 
continued to experience amenorrhea. Seventeen (5%) women were not satisfied with the 
results, and 7 (2%) underwent hysterectomy because of EA failure. Ten women (3%) 
underwent EA again. The subsequent surgery rate in my series was 5%. (8) 
Although this procedure needs training and skills, it is less expansive and underused in 
many countries. Many insurance policies such as Taiwan’s National Health Insurance do not 
cover second-generation endometrial ablation. 
Most clinicians still perform hysterectomy as the first choice in treatment of women 
presenting intractable AUB.  
The history and evolution of hysteroscopic endometrial ablation: In 1805, Bozzini described 
his simple instrument used to inspect the urethra of a living human but later was banned 
and censured for "undue curiosity."  
In 1869, Pantaleoni took the first look inside the uterine cavity using a cystoscope to observe 
and cauterize uterine polyps in a 60-year-old woman.  
In 1879, the first "modern" hysteroscope was designed and produced by Nitze by 
incorporating an interior light source with an optical system permitting magnification. 
In 1925, Rubin introduced uterine distention with carbon dioxide . 
The rod lens system designed by Harold H.Hopkins, (10) together with the fiber optic light 
transmission invented by Fourestiere in 1952, (11) has allowed extraordinary advances in 
operative hysteroscopy. 
In 1869, Pantaleoni reported the first successful hysteroscopy (using cystoscopy), when he 
described a 60-year-old woman with postmenopausal bleeding and found an intrauterine 
polyp and cauterized it with silver nitrate. This was not only the first diagnostic 
hysteroscopy but also the first demonstration of intrauterine surgery. 
Modern day operative hysteroscopy relies on two developments: the glass fiber optic for 
illumination and the uterine distention, and the hysteroscopic endometrial ablation 
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developed from the occurrence of Asherman’s syndrome that completes destruction of the 
endometrium will cause amenorrhea. 
 
Fig. 1. instrumentation for hysteroscopic endometrial ablation include rigid resectoscope, 
cables, speculum, and dilators. 
In 1976, Neuwirth & Amin used the urologic resectoscope to assist in the removal of a 
pedunculated submucous leimyomas in 5 cases. Two years later (1978) Neuwirth used a 
new hysteroscopic technique with a cutting loop and infusion distention fluid ( 32% dextran 
70) system.  
In 1979 Goldrath first performed hysteroscopic endometrial ablation by using the Nd:YAG 
laser.  
In 1981 he reported on the successful treatment of intractable uterine bleeding in 21 of 22 
cases. 
4. The general assessment and management of AUB 
The FIGO PALM-COEIN classification for abnormal uterine bleeding (AUB): 
In 2011 a new classification system for abnormal uterine bleeding (AUB) was approved by 
the FIGO Executive Board. (12) AUB, can be classified as acute, chronic, intermenstrual or 
intermittent forms, which represents a common clinical problem facing the gynecologist.  
Acute AUB was defined as an episode of heavy bleeding that is of sufficient quantity to 
require immediate intervention to prevent further blood loss.  
Chronic AUB be defined as bleeding from the uterine corpus that is abnormal in volume, 
regularity, and/or timing, and has been present for the past 6 months. Chronic AUB would 
not require immediate intervention.  
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Intermenstrual or intermediate bleeding (IMB) occurs between clearly defined cyclic and 
predictable menses. Such bleeding may occur at random times or may manifest in a 
predictable fashion at the same day in each cycle.  
The FIGO group recommended the word “metrorrhagia,” and dysfunctional bleeding 
(DUB) should be abandoned. 
Acute AUB may present in the context of existing chronic AUB or might occur without such 
a history. Although women of reproductive age with acute AUB require immediate 
intervention, their follow-up may be largely dependent upon whether they require 
investigation and ongoing care for an underlying chronic condition. 
The prevalence of AUB, the difficulties in identifying its causes, and the cost of management 
argue for reliable diagnostic techniques and treatment strategies. An ideal approach would 
promptly identify patients with organic disease, facilitate patient comprehension and choice 
of treatment options, improve treatment efficacy, and reduce overall cost of care. 
FIGO differentiates 9 categories and are arranged according to an acronym (PALM-COEIN) 
shown as below: 
AUB-P: Polyps in the endometrium that are diagnosed by ultrasound or hysteroscopy. This 
classification system does not further categorize polyps on the basis of size, location, or 
number.  
AUB-A: Adenomyosis which can be most accurately diagnosed on the basis of tissue 
analysis of a hysterectomy specimen, but in everyday clinical practice, MRI and ultrasound 
are both used to establish the diagnosis.  
AUB-L: Leiomyomas, which can be solitary or multiple, can be located close to the cavity 
(submucosal), in the myometrium (intramural), close to the outer surface (subserosal), or 
independent of the uterus (parasitic). On the basis of these characteristics, further 
subcategories have been created.  
AUB-M: Malignancy, including hyperplasia and endometrial cancer. The diagnosis requires 
the histologic analysis of a biopsy sample.  
AUB-C: Coagulopathy, which in most cases is diagnosed in adolescents. Most abnormalities 
are the result of von Willebrand disease.  
AUB-O: Ovulatory dysfunction, in which cycle length and volume of flow are 
unpredictable.  
AUB-E: Endometrial problems, typically related to abnormal prostaglandin synthesis, but 
which could be the result of infection as well.  
AUB-I: Iatrogenic causes, the result of exogenous hormone administration or anticoagulant 
therapy.  
AUB-N: Nonclassified causes such as arteriovenous malformations and myometrial 
hypertrophy. Women with both acute and chronic AUB should be evaluated for anemia. In 
the absence of any other identifiable source, the clinician would proceed in a systematic 
fashion, designing the assessment to address each of the components of the FIGO 
classification system. 
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Current treatment for AUB is recommended only when symptoms such as pain, severe 
anemia, or hydronephrosis due to ureteral obstruction are present and unacceptable to 
patients. There is no evidence that women with no symptoms or with mild symptoms 
benefit from intervention. Medical therapy such as acetaminophen and non-steroidal anti-
inflammatory drugs (NSAIDs) for pain relief is useful in some patients, but does not reduce 
uterine bleeding. A variety of hormonal therapies, mifepristone, and gonadotropin-releasing 
hormone agonists and antagonists have limited effects in reducing uterine volume and 
bleeding, but most of these treatments have not been evaluated in randomized trials.(11,12) 
Patients with ovulatory dysfunction ( AUB-O) are best treated with oral contraceptives, 
NSAIDs (antiprostaglandins), or progestins or progestin-released IUD. Cyclic use of 
progestins and oral contraceptives reduce AUB, but ergot derivatives do not.  
For patients requiring surgical alternatives, the current principal options include 
myomectomy, endometrial ablation, uterine fibroid embolization, and magnetic resonance-
guided focused ultrasound (MR-g FUS). A thoughtful discussion of the options with 
patients is essential in choosing the most appropriate treatment for patients. Selection 
among these procedures depends on the patient’s age, symptoms, and their preference. 
A large study from the United Kingdom in 2005 observed that 16,100 out of 37,298 
hysterectomies were performed as a result of AUB. 
Wade et al. suggested that for women with AUB who were older than 40 years and did not 
desire pregnancy, the best treatment trial was with oral contraceptive pills (OCPs), followed 
by second generation endometrial ablation as the most cost-effective strategy. 
Unfortunately, currently in Taiwan the second generation endometrial ablation therapy is 
not covered by Taiwan National Health Insurance. Therefore, my personal experience and 
the experience of many other investigators have demonstrated that hysteroscopic 
endometrial ablation in patients with AUB is a reasonable alternative to classic 
hysterectomy. The advantages include no abdominal incision, less discomfort, very brief 
recovery period, no hysterectomy complications, fewer psychological problems and lower 
cost. Endometrial ablation is the hysteroscopic alternative to hysterectomy as treatment for 
women with AUB. 
The pre-operative investigation procedure for women with AUB: 
It is advised to begin a work-up when a patient complaining of AUB with a pictorial blood 
assessment chart scores (PBACS) above 150 or the patient’s quality of life changes. A 
detailed clinical history and complete physical examination may reveal blood coagulation 
disorders, liver and renal disease. Laboratory studies include complete blood count (CBC), 
and monitoring of TSH, prolactin, and androgen levels if there are signs and symptoms of 
hypothyroidism, galactorrhea, hirsutism or acne. The gynecological examination with 
bimanual examination must be performed with specific attention given to the existence of 
possible lesions in the cervix, uterus, adnexa, urethra, bladder and rectum. Spe cial attention 
for the presence of endometrial cancer is also mandatory. It is mandatory to perform an 
office endometrial biopsy in all patients contemplating hysteroscopy surgery. A 
determination of uterine size is also useful because patients with uterine cavities greater 
than 10cm in length can expect less than optimal results.  
Endometrial sampling directed by hysteroscopy may increase the accuracy in evaluating 
patients with abnormal intrauterine bleeding. Ultrasound and or saline infusion sonography 
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(SIS) may detect the presence of intrauterine lesions. The abdominal and or vaginal 
ultrasound evaluation of the pelvic organs is also very helpful for operation. 
5. The procedure of the hysteroscopic endometrial ablation 
The operation is always performed under spinal anesthesia in the proliferative phase of the 
menstrual cycle; if not, then a pre-operative thorough 3-min suction curettage is done.  
Souter et al. conducted a meta-analysis about pre-operative administration of agents 
producing endometrial atrophy before surgery, and suggest it is associated with shortened 
operation times, greater rate of amenorrhea, and reduced dysmenorrhea. I prefer to pretreat 
the endometrium by trying to time the procedure in the early proliferative phase and using 
the suction curette to remove the rest of the endometrium.  
Informed consent is obtained before the operation. Misoprostol (Cytotec) 200mcg # x2 per 
vagina is given the night before operation to ripen the cervix.  
The patient is placed in the dorsal lithotomy position. A simultaneous laparoscopy is not 
performed. 
The vulva area, vagina and cervix are cleaned with disinfecting solution. A bimanual 
examination should be performed to determine whether the position of the uterus is 
anteverted or retroverted. After placing a single valve speculum in the vagina, the cervix is 
grasped with a single-toothed tenaculum which allows for traction on the cervix. The cervix 
is then dilated to Hegar No:10, 
A continuous fluid rigid hystero-resectoscope equipped with a 30 degree fore-oblique 
hysteroscope is slowly without force introduced into the uterine cavity. If there is any 
difficulty during insertion of the resectoscope, there is a risk of uterine perforation. 
The 5% dextrose is an isotonic solution with sufficient optical quality, no electric 
conductivity, no allergic potential, and is the cheapest and most readily available in 500ml 
bottle form. It is safe for endometrial ablation but the danger of fluid overload and 
pulmonary edema still exists. The uterine cavity is distended with a solution of 5% dextrose 
under a gravity feed system with a 2-litre-bottle connected to the resectoscope by urologic 
tubing. Uterine distension is created by raising the bags to a suitable height, usually 1.0-1.5 
m above the uterine cavity. Inspection of the input and output fluid volume is done every 5 
minutes by the circulating nurse during the operation. The negative balance is limited to 
2000 ml. After running distention fluid for about one minute, a clear field to see both uterine 
cornu and fundus is considered as the most important indicator that the operation can 
begin. 
I prefer partial ablation to treat the posterior wall endometrium (depth < 3 mm), initially by 
the cutting loop electrode with the current set at 120 W of cutting current. From my right 
hand side to left, both lateral side of the endometrium are resected and ablated down next to 
the isthmus. The rest of the endometrium is then coagulated using the rollerball electrode, 
with the current set at 60 W of coagulation current.  
The current total or global EA procedures cause significant intrauterine adhesion and 
contractures, and are associated with long-term adverse effects, which include painful 
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central hematometra, cornual hematometra, and postablation tubal sterilization syndrome 
in patients with tubal ligation. Postablation tubal sterilization syndrome consists of painful 
hematosalinges, resulting from active endometrial tissue near the cornual region and 
endometrial scarring and contractures that prevent menstrual egress. A partial endometrial 
ablation procedure in which only one (anterior or posterior) wall is resected and ablated was 
proposed to prevent intrauterine scarring and contractures, and thus avoid such 
complications (16, 17). This approach allows the normal endometrial surface to oppose the 
injured exposed myometrial surface, so that adhesions and contractures do not occur. To 
date, there has been only one report of a pregnancy after partial EA. This pregnancy only 
proceeded to 28 weeks of gestation, and does not yet show potential benefits for women 
wishing to retain fertility (18). 
After that any bleeding is coagulated using the roller ball electrode at a power of 40-60 W of 
coagulation current.  
For women in whom uterine polyps or myomas are found, concomitant resections are done. 
Submucosal myoma resections are carried out using unipolar cutting-loop resection 
techniques.  
All of the resected endometrial strips, myomatous fragments and polyps are sent for 
histological evaluation. 
 
Fig. 2. Placement of the loop electrode behind this 4cm submucosal myoma in a 34 year old 
woman under direct vision 
Most patients after endometrial resection will have a fairly light period for a few days, then 
become a watery pink discharge last for a week or two to three weeks. 
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The first post-operative office visit is scheduled for 1 week later, and 1 month after surgery, 
then followed up every 6 months by telephone, mail or at clinics. 
Patient satisfaction is also important to assess the question “How satisfied or dissatisfied are 
you with the result of the surgery related to menstrual flow and dysmenorrhea?” Patients 
rate their overall satisfaction on a 4-points scale(1=very satisfied, 2=satisfied, 3=dissatisfied, 
4=very dissatisfied). The need for repeat surgery or hysterectomy is also recorded. Patients 
with post-operative AUB may receive medical treatment, or if AUB, and dysmenorrhea are 
persistent, hysterectomy may be needed. 
6. The safety of the procedure 
Electrosurgical endometrial resection is not as easy as you think when watching an expert 
performing it. It is actually associated with more complications than any other procedure in 
the whole field of endoscopic surgery and performed only by obstetrician-gynecologists 
after thorough training. The most serious complications are fluid overload resulting in 
pulmonary edema and electrolytes imbalances. The first signs of pulmonary edema may 
perceived by the drop in oxygen saturation. Early and rapid treatment of furosemide and 
positive pressure ventilation may have a complete recovery. I used Dextrose 5% in water as 
the distention fluid because of its effective low-viscosity and electrolytically non-conductive 
and cheap. The most important factors predisposing to dilutional hyponatremia were 
nulliparity, type of preoperative endometrial preparation,increased uterine size and cavity 
length, concurrent myomectomy and duration of surgery. Fluid monitoring with input and 
output recording is essential during all operative hysteroscopic cases. 
Uterine perforation may occur while removal of intrauterine chips, and can cause serious 
internal organs and vascular injury if unnoticed during resection.  
There are several tips to avoiding uterine perforation complications ; 
1. Learn the physics associated with electrosurgery and the hydrodynamics inherent in 
the fluid systems used. 
2. Electrical energy should never be activated unless the surgeon can clearly see the 
operating field. 
3. The roller-ball or wire loop must always be pulled towards the operator and never 
activated when it is pushed away from the surgeon. Most important is to avoid 
perforation; it can be surprisingly difficult to detect. 
4. Always keep uterine “perforation” in mind, especially in cases with distorted uterine 
cavity and never activate the radiofrequency energy when bleeding blurs the field, as 
damage can occur to a wide variety of vessels and organs: the most dangerous 
complication is uterine perforation with electrical thermal injury and trauma.  
Trauma to major blood vessels: aorta, inferior vena cava, mesenteric artery, sacral artery, 
iliac artery. 
Trauma to bowel resulting in peritonitis and/or septicemia. 
Trauma to bladder and/or ureter requiring laparotomy or ureteric stents. 
Technique troubleshooting; 
www.intechopen.com
 Hysterectomy 
 
138 
Poor vision may be due to bleeding and debris and bubbles. 
Solution;  
Bleeding – first make sure the instrument is in the uterine cavity then increase distention 
pressure and coagulate the bleeder.  
Debris and bubbles - withdraw the scope running the distention fluid and rinse the 
perforations in the outer shaft. 
- Hemorrhage requiring balloon tamponade, laparotomy or hysterectomy or blood loss 
leading to death. 
- Distention medium overload. 
- Other rare complications such as unintended pregnancy. 
- Intrauterine adhesions and hematometra, burns. 
Nearly all of my procedures have been completed safely; however, two women sustained 
uterine perforation and underwent hysterectomies. In a third woman, the procedure was 
abandoned because of suspected endometrial malignancy. None of my patients have 
showed any signs or symptoms of fluid overload or hyponatremia.  
In my series over a 15-year-period, six pregnancies occurred after the procedure, and the 
mean age of these women was 36 years (range, 34–40 years). Because pregnancies have been 
reported after endometrial ablation, patients cannot be guaranteed that this is a sterilization 
procedure, and the risk potential for a subsequent pregnancy must be explained and 
sterilization or contraception offered. Tubal ligation does not reduce distention media 
absorption and therefore need not be a prerequisite. 
 
Fig. 3. Collection of myoma chips after resection. 
Is endometrial ablation really decreased the hysterectomy rate? 
www.intechopen.com
 Hysteroscopic Surgery as an Alternative for Hysterectomy 
 
139 
An earlier report from England suggested that the increasing use of endometrial ablation 
did not reduce the rate of hysterectomy . (19) Despite initial optimism in the United States, 
two studies showed that the hysterectomy rate remained unchanged at 5.68 per thousand 
women between 1988 and 1997. (20,21) According to a 2010 population-based NHI database 
in Taiwan , demonstrated that there have been considerable changes in the surgical types of 
hysterectomy performed in Taiwan during the last 10 years, but the annual numbers of 
hysterectomies remained stationary. (5) This means that hysteroscopic endometrial ablation 
and other alternatives to hysterecotomy are still underused in Taiwan and many parts of the 
world. Many factors might influence the selection of treatment for uterine and menstrual 
disorders, some are surgeon, and others are patient-related. Widespread critical clinical 
skills and more educations about the alternatives to hysterectomy for surgeons and patients 
are needed. 
7. Conclusion 
Hysteroscopic endometrial ablation is the logic alternative choice for women with AUB after 
failed medical treatment. 
Although hysteroscopic endometrial ablation offers many advantages, it is actually 
underused by gynecologist in the world. Every gynecologist must to learn the skill of 
diagnostic and operative hysteroscopy as their everyday routine practice. Even newer 
developments in 2nd generation global endometrial ablation, every gynecologist should 
retain their hysteroscopic operative skills whenever need. 
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